elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35190713-3C0589D0-5347-41ED-A45A-78597D0091AC
Q35190713-3C0589D0-5347-41ED-A45A-78597D0091AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35190713-3C0589D0-5347-41ED-A45A-78597D0091AC
A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study.
P2860
Q35190713-3C0589D0-5347-41ED-A45A-78597D0091AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35190713-3C0589D0-5347-41ED-A45A-78597D0091AC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d145fc417f72bb214951091ebebd2b7e393cc85
P2860
Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels.